Epstein Judith E, Rao Suchitra, Williams Frank, Freilich Daniel, Luke Thomas, Sedegah Martha, de la Vega Patricia, Sacci John, Richie Thomas L, Hoffman Stephen L
Malaria Program, Naval Medical Research Center, Silver Spring, MD, 20910, USA.
J Infect Dis. 2007 Jul 1;196(1):145-54. doi: 10.1086/518510. Epub 2007 May 29.
Challenge of volunteers by the bites of membrane-fed anopheline mosquitoes infected with Plasmodium falciparum was reported in 1986. In 1997, an analysis of experience with 118 volunteers indicated that mosquito inoculation of P. falciparum could be a safe, well-tolerated, reproducible, and efficient method of challenge.
We reviewed the records of 47 volunteers challenged at our institution with the NF54 isolate of P. falciparum between 1998 and 2002. We also reviewed data from 17 published studies of experimental challenge conducted since 1996.
At our institution, the time to onset of first symptoms (incubation period) was 8.9 days, and the time to first detectable parasitemia on blood smear (prepatent period) was 10.5 days. All volunteers became symptomatic. Most symptoms were mild to moderate, although 21% of volunteers had at least 1 severe symptom. None developed complicated or severe malaria, and all were cured. Laboratory assessments demonstrated modest, short-term abnormalities typical of malaria. Review of 17 published studies demonstrated that an additional 367 volunteers received experimental challenge safely with similar outcomes.
In total, data from 532 volunteers demonstrate that experimental challenge is safe and results in predictable incubation and prepatent periods. Our findings support the continued use of this method for testing efficacy of vaccines and drugs against P. falciparum.
1986年有关于志愿者被感染恶性疟原虫的经膜饲血按蚊叮咬的报道。1997年,对118名志愿者的经验分析表明,用恶性疟原虫进行蚊虫接种可能是一种安全、耐受性良好、可重复且有效的攻击方法。
我们回顾了1998年至2002年间在我们机构接受恶性疟原虫NF54分离株攻击的47名志愿者的记录。我们还回顾了自1996年以来发表的17项关于实验性攻击研究的数据。
在我们机构,首次出现症状的时间(潜伏期)为8.9天,血涂片上首次检测到疟原虫血症的时间(潜隐期)为10.5天。所有志愿者都出现了症状。大多数症状为轻至中度,尽管21%的志愿者至少有1种严重症状。无人发展为复杂或严重疟疾,所有患者均治愈。实验室评估显示出疟疾典型的轻度、短期异常。对17项已发表研究的回顾表明,另有367名志愿者安全地接受了实验性攻击,结果相似。
总体而言,来自532名志愿者的数据表明,实验性攻击是安全的,且会导致可预测的潜伏期和潜隐期。我们的研究结果支持继续使用这种方法来测试针对恶性疟原虫的疫苗和药物的疗效。